Who Should Be Screeened?


Prostate Conditions Education Council (PCEC) recommends a baseline prostate health assessment, including prostate specific antigen (PSA) and digital rectal exam (DRE), for all men at 40 years of age is beneficial for risk satisfaction.  Based on this initial baseline assessment, PCEC recommends that men establish an early detection follow-up schedule as stated below:

  • At risk men (Including African-American men, men with a family history of the disease, men who have been exposed to certain chemicals known to cause cancer, such as: Veterans exposed to Agent Orange and Firefighters) with a baseline PSA of .5ng/ml or greater be tested annually. If the baseline is below .5ng/ml, men should be tested every two years.
  • Men with a PSA result of less than 1.0ng/ml: should be retested in five years.
  • Men with a PSA result between 1-2ng/ml: should be retested every two years.
  • Men with a PSA result of greater than 2.0ng/ml: should be retested annually.

*PCEC does not advocate for screenings if a man’s life expectancy is less than 10 years.

Additional Information:

PCEC believes that all men should be informed of the pros and cons of early detection, diagnosis and treatment of prostate cancer.

PCEC encourages men to undergo a complete Men’s Health Evaluation and encourages a men’s health assessment which includes testing for: Testosterone, Total Triglycerides, Total Cholesterol, HDL, LDL, Glucose, PSA and new prostate cancer genomic markers and imaging tools as they become available. Men should be educated on the importance of a wellness prevention program including diet, exercise and weight.

Early detection programs are valuable for men who may not otherwise have access to or visit a physician on a regular basis.

Men must understand that screening does not diagnose cancer. Also, early detection of prostate cancer may find a cancer that does not need aggressive treatment and that the treatment options for prostate cancer often cause serious and life altering side effects.

A PSA blood test does not only look for cancer but also for other prostate abnormalities like enlarged prostates or prostate infections. A PSA of 1.5ng/ml is often used as a prostate health indicator of an issue with your prostate and it may be worth talking with a Urologist.

PCEC will continue to support the development of personalized medicine through new genomic markers for all conditions including the diagnosis and prognosis of prostate cancer through education and the unitization of our serum biorepository.